Secondly, we attempted but failed to identify any membrane receptor of ITLN1 on HCC cells, and we did not establish precisely the receptor and pathway through which ITLN1 regulates ERK1/2 signaling. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.